EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Tranexamic acid in radical cystectomy: a systematic review and meta-analysis of efficacy and safety

Maurin Helen Mangold, Victoria Luise Simone Wieland, Maurizio Grilli, Alexander Studier-Fischer, Caelán Max Haney-Aubert, Niklas Westhoff, Maurice Stephan Michel, Luisa Egen, Karl-Friedrich Kowalewski

World Journal of Urology · 2025

DOI: 10.1007/s00345-025-05939-0 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift World Journal of Urology, 2025. Verfasst von Maurin Helen Mangold und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Urosurgery, Medical Faculty Mannheim at Heidelberg University, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3,…. Hauptthemen laut MEDLINE: Cystectomy, Tranexamic Acid, Antifibrinolytic Agents, Blood Loss, Surgical. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Radical cystectomy (RC) is a high-risk procedure, associated with significant bleeding and high risk of perioperative blood transfusion (PBT), which may limit clinical and oncological outcomes. Tranexamic acid (TXA), an antifibrinolytic agent, effectively reduces bleeding in various surgical settings; however, its role in RC remains understudied. This systematic review and meta-analysis evaluates the efficacy and safety of TXA in RC patients. METHODS: A systematic search of CENTRAL, PubMed, Embase, and Web-of-Science was conducted, including studies published between January 2013 and January 2025. Four studies (one randomised controlled trial (RCT) and three retrospective cohort studies) met inclusion criteria. Data were pooled using random-effects meta-analysis. Risk of bias was assessed using ROBINS-I and RoB-2, and certainty of evidence was evaluated using GRADE. RESULTS: TXA was associated with a significant reduction in overall PBT (odds ratio (OR) 0.48, 95%-confidence interval (CI) 0.27–0.82; p = 0.008), though the only RCT included failed to identify this trend. Estimated blood loss was numerically reduced in the TXA group, but did not reach statistical significance (mean difference − 36.8 mL; 95%-CI -78.1-4.6; p = 0.08). Notably, TXA did not increase the incidence of venous thromboembolism (OR 1.49, 95%-CI 0.86–2.57; p = 0.16). Key limitations include substantial heterogeneity between studies (I² = 78% for PBT outcome), varying TXA dosing protocols, and the predominance of retrospective studies. CONCLUSION: TXA may reduce PBT requirements in RC without increasing thromboembolic risk. Further research is needed to confirm these findings, refine dosing protocols, and assess efficacy in minimally invasive RC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystectomyTranexamic AcidAntifibrinolytic AgentsBlood Loss, SurgicalUrinary Bladder NeoplasmsHumansTreatment OutcomeBlood Transfusion

Stichwörter der Autor:innen

Blood transfusionCystectomyTranexamic acidVenous thromboembolism

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Urology and Urosurgery, Medical Faculty Mannheim at Heidelberg University, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
  • German Cancer Research Center (DKFZ) Heidelberg, Division of Intelligent Systems and Robotics in Urology (ISRU), Heidelberg, Germany.
  • DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
  • Medical Library, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Department of Urology and Urosurgery, Medical Faculty Mannheim at Heidelberg University, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. karl-friedrich.kowalewski@umm.de.
  • German Cancer Research Center (DKFZ) Heidelberg, Division of Intelligent Systems and Robotics in Urology (ISRU), Heidelberg, Germany. karl-friedrich.kowalewski@umm.de.

Förderung

  • Universitätsklinikum Heidelberg

Zitieren

APA

Mangold, M. H., Wieland, V. L. S., Grilli, M., Studier-Fischer, A., Haney-Aubert, C. M., Westhoff, N., Michel, M. S., Egen, L., & Kowalewski, K. F. (2025). Tranexamic acid in radical cystectomy: a systematic review and meta-analysis of efficacy and safety. World Journal of Urology. https://doi.org/10.1007/s00345-025-05939-0

Vancouver

Mangold MH, Wieland VLS, Grilli M, Studier-Fischer A, Haney-Aubert CM, Westhoff N, et al. Tranexamic acid in radical cystectomy: a systematic review and meta-analysis of efficacy and safety. World Journal of Urology. 2025. doi:10.1007/s00345-025-05939-0

BibTeX
@article{Mangold2025,
  author = {Mangold, Maurin Helen and Wieland, Victoria Luise Simone and Grilli, Maurizio and Studier-Fischer, Alexander and Haney-Aubert, Caelán Max and Westhoff, Niklas and Michel, Maurice Stephan and Egen, Luisa and Kowalewski, Karl-Friedrich},
  title = {Tranexamic acid in radical cystectomy: a systematic review and meta-analysis of efficacy and safety},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-025-05939-0}
}
Kostenlos starten →